{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:26:18Z","timestamp":1765959978539},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.bulcan.2018.04.001","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T22:58:26Z","timestamp":1524869906000},"page":"562-572","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Protocole national Tunisien prospectif de traitement du Lymphome de Hodgkin de l\u2019adulte\u00a0: r\u00e9sultats d\u2019un sch\u00e9ma th\u00e9rapeutique adapt\u00e9 \u00e0 la r\u00e9ponse par tomodensitom\u00e9trie \u00e0 2\u00a0cycles, \u00e0 propos de 444\u00a0patients"],"prefix":"10.1016","volume":"105","author":[{"given":"Raihane","family":"Ben Lakhal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sondos","family":"Hdiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Zriba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Mokrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Adnen","family":"Laatiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yossra","family":"BenYoussef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faten","family":"Ezzaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Toumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salwa","family":"Ladeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanen","family":"BenSalah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh","family":"Tebra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Frikha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha","family":"Messai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamel","family":"Daoued","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noureddine","family":"Bouaouina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monji","family":"Maalej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mounir","family":"Frikha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"BenOthmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slim","family":"BenAhmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abderrahim","family":"Khelif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fehmi","family":"Msaddek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amel","family":"Mezlini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moez","family":"Elloumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balkis","family":"Meddeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2018.04.001_bib0110","series-title":"Registre du cancer du nord de la Tunisie (2007\u20132009)","first-page":"106","author":"Hsairi","year":"2017"},{"issue":"11","key":"10.1016\/j.bulcan.2018.04.001_bib0115","first-page":"706","article-title":"Tunisian adult's Hodgkin lymphoma study group","volume":"94","author":"Ben Lakhal","year":"2016","journal-title":"Tun Med"},{"issue":"19","key":"10.1016\/j.bulcan.2018.04.001_bib0120","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"2008\u00a0World health organization classification of lymphoid neoplasms: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bulcan.2018.04.001_bib0125","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2018.04.001_bib0130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.hoc.2007.07.004","article-title":"New strategies for the treatment of advanced stage Hodgkin's lymphoma","volume":"21","author":"Volker Diehl","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.bulcan.2018.04.001_bib0135","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.bulcan.2018.04.001_bib0140","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/pbc.24534","article-title":"Improving the prognosis of pediatric Hodgkin lymphoma in developing countries: a Moroccan Society of Pediatric Hematology and Oncology study","volume":"60","author":"Hessissen","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0145","first-page":"3","article-title":"La maladie de Hodgkin\u00a0: \u00e9tats des lieux et perspectives","volume":"10\u201311","author":"Hamladji","year":"2015","journal-title":"Rev Alg\u00e9rienne Hematol"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0150","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood.V112.11.2597.2597","article-title":"Hodgkin Lymphoma in Tunisia results of a 5\u00a0year prospective multicenter trial in 251\u00a0patients","volume":"112","author":"Ben Lakhal","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bulcan.2018.04.001_bib0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2967\/jnumed.107.039867","article-title":"18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review","volume":"49","author":"Terasawa","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0160","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Sally","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0165","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial \u00e9valuation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0170","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/annonc\/mdu181","article-title":"Hodgkin's Lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Eichenauer","year":"2014","journal-title":"Ann oncol"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/bjh.12878","article-title":"Guidelines for the first line management of classical Hodgkin Lymphoma","volume":"166","author":"Follows","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0185","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2013.51.9298","article-title":"Omitting radiotherapy in early positron emission tomography-negative stage I\/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC\/LYSA\/FIL H10\u00a0Trial","volume":"32","author":"Raemaekers","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0190","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1182\/blood.V120.21.547.547","article-title":"Involved field radiotherapy versus no further treatment in patients with clinical stages IA and IIA Hodgkin lymphoma and a \u2018negative\u2019 PET scan after 3\u00a0cycles ABVD. Results of the UK NCRI RAPID trial","volume":"120","author":"Radford","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0195","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2010.29.8018","article-title":"Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11\u00a0trial","volume":"28","author":"Eich","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0200","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1470-2045(13)70341-3","article-title":"Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis","volume":"14","author":"Skoetz","year":"2013","journal-title":"Lancet oncol"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0205","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(11)61940-5","article-title":"Reduced-intensity chemotherapy and PET guided radiotherapy in patients with advanced stage Hodgkin lymphoma (HD15\u00a0trial): a randomized open-label phase 3\u00a0non-inferiority trial","volume":"379","author":"Engert","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2018.04.001_bib0105","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1182\/blood-2011-09-378414","article-title":"A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcome and prognostic factors in modern era","volume":"119","author":"Andrew","year":"2012","journal-title":"Blood"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455118301267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455118301267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T10:19:18Z","timestamp":1604225958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455118301267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0007455118301267"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2018.04.001","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocole national Tunisien prospectif de traitement du Lymphome de Hodgkin de l\u2019adulte\u00a0: r\u00e9sultats d\u2019un sch\u00e9ma th\u00e9rapeutique adapt\u00e9 \u00e0 la r\u00e9ponse par tomodensitom\u00e9trie \u00e0 2\u00a0cycles, \u00e0 propos de 444\u00a0patients","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2018.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}